The report provides a detailed analysis essential for establishing a Prucalopride production plant. It encompasses all critical aspects necessary for Prucalopride production, including the cost of Prucalopride production, Prucalopride plant cost, Prucalopride production costs, and the overall Prucalopride production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Prucalopride production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Prucalopride is a simple medicine that helps adults with long-term idiopathic constipation. It is mainly utilised in ongoing bowel problems that have no clear cause, and when regular laxatives don't work well. It stimulates bowel movements by turning on special 5-HT4 receptors there, which boost natural movements in the intestines. It leads to more frequent and complete spontaneous bowel movements (three or more per week), reduced straining, less bloating, and improved quality of life.
It is also utilised in gastroparesis or constipation-type irritable bowel syndrome, helping improve daily comfort. Its common side effects include headache, nausea, diarrhoea, abdominal pain, dizziness, fatigue, vomiting, flatulence, decreased appetite, bloating, and indigestion.
The market for Prucalopride is driven by growing cases of chronic idiopathic constipation (CIC) and constipation-predominant irritable bowel syndrome (IBS-C). The ageing global populations, sedentary lifestyles, dietary shifts, and heightened awareness through better diagnostics contribute to its market growth.
The expanding healthcare infrastructure with favourable reimbursement policies for GI therapies and rising telemedicine and online pharmacy adoption fuel its market. The R&D into novel formulations, combinations, and the presence of generics boost its demand. The industrial Prucalopride procurement is affected by strict requirements for API purity, along with regulatory compliance with GMP, DMF, CEP, or EDQM certifications. Other factors like volatile pricing due to raw material costs, synthesis complexity, and quality assurance via CoA and MSDS documentation impact its sourcing.
Raw Material for Prucalopride Production
According to the Prucalopride production plant project report, the key raw materials used in the production of Prucalopride include 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid (AC-DHBFA) | 1-(3-methoxypropyl)-4-piperidinamine |1,1'-carbonyldiimidazole.
Production Process of Prucalopride
The extensive Prucalopride production cost report consists of the following major industrial production process:
- From AC-DHBFA: The production process of Prucalopride starts with activating 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid in THF. To this mix, a solution of 1-(3-methoxypropyl)-4-piperidinamine is added dropwise, followed by water addition to precipitate the solid. This is stirred, filtered, rinsed, and dried to give Prucalopride as the final product.
Prucalopride is a white to beige crystalline powder with the molecular formula C18H26ClN3O3 and molecular weight of 367.87 g/mol. It exists in solid form with a melting point of around 90.7 degree Celsius and a boiling point of 481.4 degree Celsius. It has a density of 1.28 g/cm³ and moderate lipophilicity with a logP value of 2.56. It exhibits pKa values near 8.5-13.65, indicating basic character from its piperidine moiety. It has low water solubility but high solubility in DMSO, DMF, and ethanol. It has a polar surface area of 76.82 Ų and a volume of distribution of 623 L with 30% plasma protein binding. It requires storage at 2-8 degree Celsius for better stability.